Cargando…

Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein

Approximately one fifth of all malignancies worldwide are etiologically associated with a persistent viral or bacterial infection. Thus, there is a particular interest in therapeutic molecules which use components of a natural immune response to specifically inhibit oncogenic microbial proteins, as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Togtema, Melissa, Hussack, Greg, Dayer, Guillem, Teghtmeyer, Megan R., Raphael, Shalini, Tanha, Jamshid, Zehbe, Ingeborg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539864/ https://www.ncbi.nlm.nih.gov/pubmed/31035322 http://dx.doi.org/10.3390/ijms20092088

Ejemplares similares

Virus–Host Protein–Protein Interactions between Human Papillomavirus 16 E6 A1 and D2/D3 Sub-Lineages: Variances and Similarities
por: Dayer, Guillem, et al.
Publicado: (2020)

Sonoporation Delivery of Monoclonal Antibodies against Human Papillomavirus 16 E6 Restores p53 Expression in Transformed Cervical Keratinocytes
por: Togtema, Melissa, et al.
Publicado: (2012)

An update on antibody-based immunotherapies for Clostridium difficile infection
por: Hussack, Greg, et al.
Publicado: (2016)

Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives (†)
por: Hussack, Greg, et al.
Publicado: (2010)

Tumourigenesis Driven by the Human Papillomavirus Type 16 Asian-American E6 Variant in a Three-Dimensional Keratinocyte Model
por: Jackson, Robert, et al.
Publicado: (2014)

Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody
por: Sulea, Traian, et al.
Publicado: (2018)

Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability
por: Hussack, Greg, et al.
Publicado: (2011)

Multivalent Anchoring and Oriented Display of Single-Domain Antibodies on Cellulose
por: Hussack, Greg, et al.
Publicado: (2009)

Isolation and characterization of camelid single-domain antibodies against HER2
por: Hussack, Greg, et al.
Publicado: (2018)

Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease
por: Kandalaft, Hiba, et al.
Publicado: (2015)

Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential
por: Zehbe, Ingeborg, et al.
Publicado: (2011)

Sonoporation efficacy on SiHa cells in vitro at raised bath temperatures—experimental validation of a prototype sonoporation device
por: Kivinen, Jonathan, et al.
Publicado: (2015)

Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human V(H)/V(L) Single-Domain Antibodies from In Vitro Display Libraries
por: Henry, Kevin A., et al.
Publicado: (2017)

Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein
por: Wang, Yan, et al.
Publicado: (2014)

Neutralization of Clostridium difficile toxin B with V(H)H-Fc fusions targeting the delivery and CROPs domains
por: Hussack, Greg, et al.
Publicado: (2018)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

A Novel Affinity Tag, ABTAG, and Its Application to the Affinity Screening of Single-Domain Antibodies Selected by Phage Display
por: Hussack, Greg, et al.
Publicado: (2017)

Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58
por: Brendle, Sarah A., et al.
Publicado: (2010)

Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology
por: Jackson, Robert, et al.
Publicado: (2016)

Erratum to: Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology
por: Jackson, Robert, et al.
Publicado: (2016)

Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging
por: Bates, David, et al.
Publicado: (2014)

Structure-guided design of a potent Clostridioides difficile toxin A inhibitor
por: Hussack, Greg, et al.
Publicado: (2023)

Corrigendum: Structure-guided design of a potent Clostridioides difficile toxin A inhibitor
por: Hussack, Greg, et al.
Publicado: (2023)

Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda
por: Waddell, K, et al.
Publicado: (2003)

Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS Diseases
por: Bélanger, Kasandra, et al.
Publicado: (2019)

Monoclonal Antibodies in Cancer
por: Ghosh, A.K.
Publicado: (1986)

Pharmacokinetics of Monoclonal Antibodies
por: Ryman, Josiah T., et al.
Publicado: (2017)

Microbials for the production of monoclonal antibodies and antibody fragments
por: Spadiut, Oliver, et al.
Publicado: (2014)

An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies
por: Estep, Patricia, et al.
Publicado: (2015)

Delivering Monoclonal Antibody Infusions to Novel Outpatient Settings
por: Minnich, Amy, et al.
Publicado: (2022)

Detection of Human Antibody against the Human Papillomavirus Type 16 E7 Protein
por: Hashido, Madoka, et al.
Publicado: (1991)

From rabbit antibody repertoires to rabbit monoclonal antibodies
por: Weber, Justus, et al.
Publicado: (2017)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
por: Radocha, Jakub, et al.
Publicado: (2021)

Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease
por: Kämmer, C, et al.
Publicado: (2002)

Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies
por: Chicheportiche, Yves, et al.
Publicado: (2002)

Monoclonal Antibodies to the Thyrotropin Receptor
por: Ando, Takao, et al.
Publicado: (2005)

Monoclonal antibodies for imaging and therapy.
por: Epenetos, A. A., et al.
Publicado: (1989)

Drug-targeting by monoclonal antibodies.
por: Embleton, M. J.
Publicado: (1987)

Monoclonal Antibodies in Clinical Medicine
por: Moore, M.
Publicado: (1983)

Monoclonal Antibodies as Diagnostics; an Appraisal
por: Siddiqui, M. Z.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8i8s8drpvi81i0q1im3phf1nl0